AGO vs CNO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a weak Piotroski F-Score of 3/9, indicating poor financial health, while the absence of an Altman Z-Score prevents a definitive distress risk assessment. Despite this, AGO trades below the Graham Number of $148.07 at $83.26, suggesting potential undervaluation, supported by a low P/E of 10.36 versus sector average of 22.56. However, declining earnings growth (YoY: -31.20%) and negative insider sentiment counterbalance value appeal. Analysts recommend a 'buy' with a $107.00 target, implying upside, but inconsistent quarterly execution and bearish technical trend temper near-term optimism.
CNO presents a conflicting profile: while the company demonstrates a strong track record of earnings beats and a stable Piotroski F-Score of 4/9, it is currently trading at a significant premium to its Intrinsic Value ($16.10) and Graham Number ($38.01). The valuation is supported by a low forward P/E of 8.92, but this is offset by a highly bearish technical trend (10/100) and aggressive insider selling. Overall, the strong operational performance is currently decoupled from the deteriorating insider sentiment and technical momentum.
Compare Another Pair
Related Comparisons
AGO vs CNO: Head-to-Head Comparison
This page compares Assured Guaranty Ltd. (AGO) and CNO Financial Group, Inc. (CNO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.